E106D (p.Glu106Asp) variant of ABL2 (Tyrosine-protein kinase ABL2)
E106D (p.Glu106Asp) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data.
E106D (p.Glu106Asp) variant details
- p.Glu106Asp
- ExAC rs763949080
- gnomAD rs763949080
- Missense
- Variant Prioritization Score for Impact Estimate 0.312
- REVEL 0.13
- CADD 22.70
- PolyPhen-2 0.04
- SIFT 0.02
- Population evidence available